Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine in β-thalassemia patients with cardiac iron overload
IRCT20090613002027N16Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of amlodipine in beta thalassemia (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Malondialdehyde, Protein carbonyl and 1 more. Started Jan 2019; status: completed.
02
Drugs
amlodipine
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on IRCT20090613002027N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090613002027N16.